Loading…
Use of Methylphenidate for the Management of Fatigue in Chinese Patients With Cancer
Reason for the Study: Studies on methylphenidate for cancer-related fatigue showed conflicting results. This prospective study aims to determine whether methylphenidate is useful for relieving fatigue in Chinese patients with cancer. Chinese Version of Brief Fatigue Inventory (BFI-C) was administere...
Saved in:
Published in: | American journal of hospice & palliative medicine 2014-05, Vol.31 (3), p.281-286 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Reason for the Study:
Studies on methylphenidate for cancer-related fatigue showed conflicting results. This prospective study aims to determine whether methylphenidate is useful for relieving fatigue in Chinese patients with cancer. Chinese Version of Brief Fatigue Inventory (BFI-C) was administered on days 1, 8, and 29. Methylphenidate dose on day 1 was 5 mg daily then adjusted after day 8 according to response and side effects tolerance.
Main Findings:
Only 48% of the 25 recruited patients were on methylphenidate by day 29. Overall, no significant improvement in fatigue level was observed after methylphenidate, though benefits were shown in subgroups with age ≤ 65 and higher baseline BFI-C values.
Principal Conclusions:
Methylphenidate may be useful for management of cancer-related fatigue in selected Chinese patients. |
---|---|
ISSN: | 1049-9091 1938-2715 |
DOI: | 10.1177/1049909113487022 |